Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
    • Our Story
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

Three University of Barcelona spin-offs receive funding from Women TechEU

Highlights, News
Three University of Barcelona spin-offs led by women will receive funding as part of the Women TechEU pilot callFundació Bosch i Gimpera

THREE UNIVERSITY OF BARCELONA SPIN-OFFS LED BY WOMEN WILL RECEIVE FUNDING AS PART OF THE WOMEN TechEU PILOT CALL.

NIMBLE Diagnostics, Gate2Brain and ColorSensing, spin-offs from the Universitat de Barcelona , ​​have been selected as part of the Women TechEU pilot call, a new European Union program that supports emerging Deep Tech companies led by women.

The three UB spin-offs will this year receive an individual grant of 75,000 euros to support the first steps of their innovation process and the growth of their company. In addition, they will be offered advice under the Women’s Leadership Program of the European Innovation Council and SMEs Executive Agency (EISMEA) and dedicated networking opportunities across the EU.

Source: http://www.fbg.ub.edu/actualitat/tres-spin-off-de-la-ub-liderades-per-dones-rebran-financament-en-el-marc-de-la-convocatoria-pilot-women-techeu/

December 15, 2022/by noticias
Tags: Biotech, Gate2Brain, Innovation, research, womenentrepreneur, WomenTechEu
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2023/04/Captura-de-pantalla-2023-04-25-a-las-7.39.46.png 406 792 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-12-15 15:31:512025-03-19 11:31:53Three University of Barcelona spin-offs receive funding from Women TechEU
You might also like
medicines beyond barriersG2BMedicines beyond barriers
Every milestone matters. Together, they shaped our journey.
10 Top Biotech Startups to Watch in 2023StartUs10 Top Biotech Startups to Watch in 2023
talento científicotalento cientificoFounding a company in times of pandemic
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge
Biotech New Frontiers Award 2022Gate2BrainG2B awarded with Biotech New Frontiers 2022
Gate2Brain attends the 1st edition of the, Fundació Bosch i Gimpera, University of Barcelona spin-offs gathering “Cockroaches vs Unicorns”universitat de barcelonaGate2Brain attends the 1st edition of the University of Barcelona spin-offs “Cockroaches vs Unicorns”
THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansiónTHIS IS HOW A DRUG IS TOWED TO THE BRAIN

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Gate2Brain Selected for the EU Business Hub Mission at World Health Expo Osaka 2026June 23, 2026 - 13:31
  • Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025November 3, 2025 - 10:23
  • Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery SolutionsOctober 15, 2025 - 12:56
  • Gate2Brain turns 5!July 9, 2025 - 18:07
  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Sometimes the impossible only comes laterTHIS IS HOW A DRUG IS TOWED TO THE BRAINExpansiónTHIS IS HOW A DRUG IS TOWED TO THE BRAIN
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}